Corteva (CTVA) 주식 개요
는 농업 사업을 운영합니다. 자세히 보기
CTVA Community Fair Values
Create NarrativeSee what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Corteva, Inc. 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | US$82.83 |
| 52주 최고가 | US$85.63 |
| 52주 최저가 | US$60.54 |
| 베타 | 0.59 |
| 1개월 변동 | -1.19% |
| 3개월 변동 | 11.60% |
| 1년 변동 | 21.88% |
| 3년 변동 | 43.06% |
| 5년 변동 | 79.21% |
| IPO 이후 변동 | 233.86% |
최근 뉴스 및 업데이트
Recent updates
내러티브 업데이트 • Apr 27
CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation
Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.내러티브 업데이트 • Apr 13
CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation
The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.내러티브 업데이트 • Mar 28
CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance
The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.내러티브 업데이트 • Mar 12
CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance
The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.내러티브 업데이트 • Feb 26
CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance
Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.내러티브 업데이트 • Feb 11
CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects
Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.내러티브 업데이트 • Jan 26
CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects
Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.내러티브 업데이트 • Jan 11
CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power
Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.Seeking Alpha • Jan 10
Corteva: Get Your Piece Of SpinCo As A Stable Portfolio Compounder
Summary Corteva is splitting into two pure-play companies, with the seed segment (SpinCo) offering superior stability and margin profile. I rate CTVA a buy, driven by SpinCo's consistent revenue growth, high operating margins (26%), and robust market position in seeds, especially corn. SpinCo trades at an implied 9.3x EV/EBITDA, below sector and CTVA's historical average, with potential for significant buybacks and dividend increases post-separation. Key risk is U.S. isolationism; deteriorating U.S.-China trade could impact corn and soybean sales, potentially altering the investment thesis. Read the full article on Seeking Alpha내러티브 업데이트 • Dec 18
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.내러티브 업데이트 • Dec 03
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.분석 기사 • Nov 26
A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)
Key Insights Corteva's estimated fair value is US$63.85 based on 2 Stage Free Cash Flow to Equity Current share price...내러티브 업데이트 • Nov 19
CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value
The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.내러티브 업데이트 • Nov 05
CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment
Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.내러티브 업데이트 • Oct 22
Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift
Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.내러티브 업데이트 • Oct 08
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.내러티브 업데이트 • Sep 04
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.분석 기사 • Aug 26
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend from last year's comparable payment on the 15th of September to...분석 기사 • Aug 01
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend on the 15th of September to $0.18, which is 5.9% higher than...분석 기사 • Jul 28
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings
With a price-to-earnings (or "P/E") ratio of 43.9x Corteva, Inc. ( NYSE:CTVA ) may be sending very bearish signals at...분석 기사 • Jul 14
We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Apr 21
Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance
Summary Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks. Improved valuation at 20x forward earnings, solid balance sheet, and technical indicators suggest potential for further upside in the current market environment. Read the full article on Seeking AlphaSeeking Alpha • Mar 30
Pure Market Inefficiency In Corteva Preferreds Pricings
Summary This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio. On 02/10/2025, technical high-volume buying in CTA-A turned our initial investment idea into a pair trade. This pair trade highlights how technical factors can create profitable opportunities in fixed-income securities, especially among identical issues from the same issuer. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
CTA.PR.B: An Undervalued Investment-Grade Opportunity From Corteva
Summary CTA-B offers a 6.32% current yield, making it an attractive investment-grade preferred stock with solid financial backing from Corteva, Inc. Corteva, Inc.'s strong financial health and low leverage ensure the safety of uninterrupted dividend distributions for CTA-B shareholders. Comparative analysis shows CTA-B is undervalued, offering a potential 10% capital appreciation relative to its peers and Corteva's OTC bonds. Corteva's BBB credit rating and low-risk perception in the bond market further reinforce the security and value of investing in CTA-B. Read the full article on Seeking AlphaSeeking Alpha • Jan 10
Corteva: A Wide-Moat Play On Commodity Prices
Summary Corteva is a strong defensive play for stagflation with its wide economic moat in seeds, providing exposure to agricultural commodities and a growing dividend. The company has shown impressive performance since its 2019 spin-off, with growth in gross profits and operating income exceeding revenue growth, reflecting strong operating efficiency. Corteva faces risks such as regulatory and ESG concerns, pricing pressure in crop protection, and currency fluctuations, but remains a resilient and diversified investment. I rate Corteva a "Buy" for its defensive characteristics, allowing investors to gain commodity exposure as a best-in-breed operator. Read the full article on Seeking AlphaSeeking Alpha • Nov 10
Corteva Q3: Lower Commodity And Raw Material Costs Ahead, Potential Margin Expansion
Summary I reiterate a 'Buy' rating for Corteva with a fair value target of $68 per share, driven by anticipated margin expansion and end-market recovery. Corteva's Q3 results showed weak growth in Latin America, but benefits from raw material cost deflation and cost management are expected to enhance margins in FY25. Management forecasts a flat crop protection market for FY25, with significant cost reductions from lower seed commodity costs and deflationary raw materials. Despite near-term price/mix challenges, lower input costs could be a major catalyst for margin expansion, supporting the stock's undervaluation and 'Buy' recommendation. Read the full article on Seeking Alpha주주 수익률
| CTVA | US Chemicals | US 시장 | |
|---|---|---|---|
| 7D | 1.4% | 1.7% | 2.6% |
| 1Y | 21.9% | 9.6% | 26.2% |
수익률 대 산업: CTVA은 지난 1년 동안 9.6%의 수익을 기록한 US Chemicals 산업보다 더 좋은 성과를 냈습니다.
수익률 대 시장: CTVA은 지난 1년 동안 26.2%를 기록한 US 시장보다 저조한 성과를 냈습니다.
주가 변동성
| CTVA volatility | |
|---|---|
| CTVA Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
안정적인 주가: CTVA는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: CTVA의 주간 변동성(3%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 1802 | 21,500 | Chuck Magro | www.corteva.com |
는 농업 사업을 운영합니다. 이 회사는 종자 및 작물 보호의 두 가지 부문을 통해 운영됩니다. 종자 부문은 농장에 최적의 수확량을 제공하는 첨단 생식체와 형질을 개발 및 공급합니다.
Corteva, Inc. 기초 지표 요약
| CTVA 기초 통계 | |
|---|---|
| 시가총액 | US$54.26b |
| 순이익 (TTM) | US$1.25b |
| 매출 (TTM) | US$17.89b |
44.2x
주가수익비율(P/E)3.1x
주가매출비율(P/S)CTVA는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| CTVA 손익계산서 (TTM) | |
|---|---|
| 매출 | US$17.89b |
| 매출원가 | US$9.20b |
| 총이익 | US$8.69b |
| 기타 비용 | US$7.44b |
| 순이익 | US$1.25b |
최근 보고된 실적
Mar 31, 2026
다음 실적 발표일
해당 없음
| 주당순이익(EPS) | 1.87 |
| 총이익률 | 48.56% |
| 순이익률 | 7.00% |
| 부채/자본 비율 | 13.6% |
CTVA의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기| Corteva 배당 일정 | |
|---|---|
| 배당락일 | Jun 01 2026 |
| 배당 지급일 | Jun 15 2026 |
| 배당락일까지 남은 일수 | 20 days |
| 배당 지급일까지 남은 일수 | 34 days |
CTVA는 안정적으로 배당을 지급합니까?
CTVA 배당 기록 및 벤치마크 보기기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/11 10:35 |
| 종가 | 2026/05/11 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Corteva, Inc.는 39명의 분석가가 다루고 있습니다. 이 중 19명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| null null | Argus Research Company |
| Benjamin Theurer | Barclays |
| Benjamin Theurer | Barclays |